Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3. Weller J, Katzendobler S, Blobner J, Thiele F, et al. J Neurooncol 2022;160:149-158.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weller J, Katzendobler S, Blobner J, Thiele F, et al. Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3. J Neurooncol 2022;160:149-158.
PMID: 36112301